H-KYSPSNVKI-OH

Ref. 3D-PP49820

Informations sur le produit

• Nom: H-KYSPSNVKI-OH

Description

Peptide H-KYSPSNVKI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KYSPSNVKI-OH include the following: Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model M Fukuda, J Nakamura, S Ito, K Kawazoe, Y Miyanaga - Vaccine, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X21005612 Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen K Haq, Y Jia, SM Elahi, S MacLean, B Akache - Vaccine, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X19311685 Reduction of influenza A virus transmission in mice by a universal intranasal vaccine candidate is long-lasting and does not require antibodies GE Price , CY Lo, JA Misplon, SL Epstein - Journal of Virology, 2022 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00320-22 Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection G Betts, H Poyntz, E Stylianou, A Reyes-Sandoval - PLoS , 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050447 Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based Immunization D Schöne, CP Hrycak, S Windmann - Journal of , 2017 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01184-17

• Marque: Biosynth